Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 51208
MIM: 609210
HGNC: 2039
Ensembl: ENSG00000066405
Variants:
dbSNP: 51208
ClinVar: 51208
TCGA: ENSG00000066405
COSMIC: CLDN18
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000066405 | ENST00000183605 | P56856 |
| ENSG00000066405 | ENST00000343735 | P56856 |
| ENSG00000066405 | ENST00000479660 | F8WEY4 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38060154 | 2024 | Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study. | 0 |
| 38724721 | 2024 | Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination. | 0 |
| 38749447 | 2024 | Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer. | 0 |
| 38843446 | 2024 | Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer. | 0 |
| 38060154 | 2024 | Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study. | 0 |
| 38724721 | 2024 | Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination. | 0 |
| 38749447 | 2024 | Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer. | 0 |
| 38843446 | 2024 | Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer. | 0 |
| 36639622 | 2023 | Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours. | 4 |
| 36730833 | 2023 | Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary. | 1 |
| 36793190 | 2023 | Claudin18.2 expression and clinicopathological features in cytology effusion specimens from gastric adenocarcinoma: A comparative study with tissue specimens. | 3 |
| 37046312 | 2023 | FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer. | 10 |
| 37487317 | 2023 | Correlation of Claudin18.2 expression with clinicopathological characteristics and prognosis in gastric cancer. | 0 |
| 36639622 | 2023 | Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours. | 4 |
| 36730833 | 2023 | Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary. | 1 |
Citation
Dessen P
CLDN18 (claudin 18)
Atlas Genet Cytogenet Oncol Haematol. 2007-09-01
Online version: http://atlasgeneticsoncology.org/gene/49740/cldn18-(claudin-18)
